Back |
home / stock / nltx / nltx message board
Subject | By | Source | When |
---|---|---|---|
Thanks for trying, mick. P.S. The all | Schrogtergracht | investorshub | 01/14/2021 11:54:37 PM |
IT IS TOO$ OLD TO GET IT | mick | investorshub | 01/14/2021 11:35:18 PM |
Does anybody here regularly speak to somebody of | Schrogtergracht | investorshub | 01/14/2021 11:27:43 PM |
We have big plans for $NLTX. But that | Schrogtergracht | investorshub | 01/14/2021 11:19:56 PM |
That's fine with me, mick. I was irritated | Schrogtergracht | investorshub | 01/14/2021 11:07:49 PM |
Neoleukin Therapeuti ($NLTX) | mick | investorshub | 01/14/2021 2:42:43 AM |
https://pennystocks.news/otc/?symbol=$NLTX | mick | investorshub | 01/03/2021 6:16:14 PM |
Wonderful. That's why the range? Merry Christmas everybody. | Schrogtergracht | investorshub | 12/25/2020 7:28:20 PM |
znewcar1: NLTX 35% v7,3M c14.56 f41,9M H17.95 S13.56 gap n go to HOD S | znewcar1 | investorshangout | 12/24/2020 10:18:18 PM |
Neo-2/15 is very small and very stable. Because | Schrogtergracht | investorshub | 12/23/2020 11:27:21 PM |
The over-civilized 'civilisations': | Schrogtergracht | investorshub | 12/23/2020 10:16:13 PM |
Another 10%, please. 9.66? Thx | Schrogtergracht | investorshub | 12/23/2020 8:51:11 PM |
The medical equivalent of bitcoin. | Schrogtergracht | investorshub | 12/23/2020 6:31:03 PM |
Why would Gates let this go? | Schrogtergracht | investorshub | 12/23/2020 4:50:51 PM |
znewcar1: NLTX 19% v1,7M c12.72 f38M H13.43 | znewcar1 | investorshangout | 12/23/2019 9:49:29 PM |
znewcar1: NLTX 26% v3,3M c7.96 f38M H 8.55 S@7.70 | znewcar1 | investorshangout | 12/10/2019 9:57:15 PM |
znewcar1: NLTX 54% v2,1M c6.28 f38M H 7.18 Gap up into 5 S@4.75 R@5.75 & 7 S@6.2 @5.5 | znewcar1 | investorshangout | 12/09/2019 11:00:18 PM |
znewcar1: NLTX 21% v1,1M c5.14 f38M H5.43 morning rip S4.32 with in an hour than sideways. | znewcar1 | investorshangout | 11/26/2019 9:24:03 PM |
znewcar1: NLTX 22% v393K c4.24 f38M H 4.45 virgin post | znewcar1 | investorshangout | 11/26/2019 3:49:20 AM |
News, Short Squeeze, Breakout and More Instantly...
Neoleukin Therapeutics Inc. Company Name:
NLTX Stock Symbol:
NYSE Market:
SEATTLE, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical company that has designed de novo protein therapeutics utilizing sophisticated computational methods, today announced that its B...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Neoleukin Therapeutics Inc. (NLTX) is expected to report $-0.8 for Q3 2023